MedTech News
.................... by Andrew Celentano
U.S. FDA Grants Breakthrough Device Designation to Artera’s AI-Powered Prostate Cancer Decision Support Tool
Innovative software platform leverages artificial intelligence to personalize therapy decisions and improve clinical outcomes for prostate cancer patients.
SimBioSys Earns Third FDA Clearance for TumorSight™ Viz
AI-Powered 3D Surgical Planning Tool Advances Precision Breast Cancer Surgery with Latest Regulatory Milestone
Abbott earns Medicare win for TriClip TEER system
Abbott (NYSE: ABT)+
announced that it received a Medicare win related to its TriClip TEER system.
FDA clears Intuitive curved vessel sealer device for surgical robot
Intuitive Surgical (Nasdaq: ISRG)+
announced today that the FDA cleared the latest advanced energy instrumentation for its da Vinci systems.
Synchrony Medical Receives 510(k) FDA Clearance for LibAirty™ Airway Clearance System for At-Home Respiratory Relief
JERSEY CITY, N.J. and OR YEHUDA, Israel, July 10, 2025 /PRNewswire/ — Synchrony Medical, a medical technology company dedicated to advancing respiratory care, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its LibAirty™ Airway Clearance System in the United States.
Dymicron Granted IDE Approval for Triadyme-C Artificial Disc
OREM, Utah, July 10, 2025 /PRNewswire/ — Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United States (U.S.) Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to begin a pivotal clinical study of the Triadyme®–C cervical artificial disc.
Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
The FDA has granted 510(k) clearance to the TaviPilot AI software developed by Caranx Medical, according to company officials.
Substances isolated from marine sponges show potential for treating malaria
Brazilian researchers have discovered chemical compounds in marine sponges that have the potential to eliminate the malaria parasite, including strains that are resistant to conventional antimalarial drugs. The research results were published in the journal ACS Infectious Diseases.